Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
Nuri Lee, Seri Jeong, Su Kyung Lee, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1143-1143
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort
Masae Itamochi, Shunsuke Yazawa, Noriko Inasaki, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2234-2242
Open Access | Times Cited: 14
Monitoring Humoral Immune Response Following COVID-19 Immunization and Booster Dose: A Prospective Study in Tunisian Healthcare Workers
Chiraz Naffouti, Hela Hannachi, Wafa Aissi, et al.
Journal of Clinical Virology Plus (2025), pp. 100210-100210
Open Access
A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
‪Yasmin Maor‬‏, Eilat Shinar, Marina Izak, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 7, pp. 964-971
Open Access | Times Cited: 10
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
Noemi Castelletti, Ivana Paunović, Raquel Rubio‐Acero, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
Dóra Németh, Hajnalka Vágó, László Tóthfalusi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
Ursino Pacheco-García, Jeanet Serafín‐López
Vaccines (2023) Vol. 11, Iss. 3, pp. 655-655
Open Access | Times Cited: 7
Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample
Jina Han, Hye Jin Baek, Eunbi Noh, et al.
Epidemiology and Health (2023) Vol. 45, pp. e2023075-e2023075
Open Access | Times Cited: 7
Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial
Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3999-4010
Open Access | Times Cited: 2
Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV
Akshita Gupta, Elda Righi, Angelina Konnova, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 8
Open Access | Times Cited: 2
210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1703-1703
Open Access | Times Cited: 10
Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea
Jin Young Ahn, Jae‐Hoon Ko, Kyong Ran Peck, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 5
Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response
Y. Victoria Zhang, Attila Kumánovics, Joesph R Wiencek, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 292-292
Open Access | Times Cited: 1
Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology
Timothy D. Carroll, Talia S. Wong, Mary Kate Morris, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
COVID-19 in patients with classic and variant hairy cell leukemia
Robert J. Kreitman, Theresa Yu, Lacey James, et al.
Blood Advances (2023) Vol. 7, Iss. 23, pp. 7161-7168
Open Access | Times Cited: 4
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus
Jakub Swadźba, Andrzej Panek, Paweł Wąsowicz, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 471-471
Open Access | Times Cited: 1
IL-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV (PLWH)
Akshita Gupta, Elda Righi, Angelina Konnova, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination
Sanja Zember, Kristian Bodulić, Nataša Cetinić Balent, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1813-1813
Open Access | Times Cited: 7
The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech Booster
Blanka Wolszczak-Biedrzycka, Anna Bieńkowska, Elwira Smolińska-Fijołek, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 7811-7821
Open Access | Times Cited: 7
Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients
Abdel-Ellah Al-Shudifat, Mohammad Al‐Tamimi, Rand Dawoud, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1398-1398
Open Access | Times Cited: 2
Effect of COVID-19 infection and vaccination on SARS-CoV-2 antibody titer change following ovarian stimulation: Prospective analysis of IVF outcomes
So–Youn Shin, J. Kim, Ji Hyang Kim, et al.
Medicine (2024) Vol. 103, Iss. 11, pp. e37349-e37349
Open Access
Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation
Z. E. Afridonova, А. П. Топтыгина, Е. Л. Семикина
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 1, pp. 35-45
Open Access
Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia
Awatef Ben Jemaa, Rihab Bouabsa, Meriam Ben Othmen, et al.
La Tunisie Médicale (2024) Vol. 102, Iss. 8
Closed Access
COVID-19 vaccination in patients with classic and variant hairy cell leukemia
Robert J. Kreitman, Lacey James, Julie Feurtado, et al.
Deleted Journal (2024) Vol. 1, Iss. 4, pp. 100035-100035
Open Access
Page 1 - Next Page

Scroll to top